1. Home
  2. LAW vs CRVS Comparison

LAW vs CRVS Comparison

Compare LAW & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CS Disco Inc.

LAW

CS Disco Inc.

HOLD

Current Price

$6.35

Market Cap

466.2M

Sector

Technology

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$22.24

Market Cap

546.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAW
CRVS
Founded
2013
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
466.2M
546.7M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
LAW
CRVS
Price
$6.35
$22.24
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$9.00
$17.75
AVG Volume (30 Days)
143.9K
5.6M
Earning Date
02-19-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$152,677,000.00
N/A
Revenue This Year
$8.51
N/A
Revenue Next Year
$8.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.33
N/A
52 Week Low
$3.31
$2.54
52 Week High
$9.11
$22.10

Technical Indicators

Market Signals
Indicator
LAW
CRVS
Relative Strength Index (RSI) 29.11 91.59
Support Level $7.11 $6.46
Resistance Level $7.52 $7.18
Average True Range (ATR) 0.34 1.42
MACD -0.17 1.56
Stochastic Oscillator 10.86 90.50

Price Performance

Historical Comparison
LAW
CRVS

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: